“President Donald Trump has until November to pick a new leader for the Food and Drug Administration, but his health and human services secretary already has someone in mind, according to a news report.”
“Citing officials within the Trump administration, BioCentury reported Thursday that HHS Secretary Alex Azar was considering nominating his assistant secretary of HHS for health, Brett Giroir, to the head the agency. By law, Donald Trump must choose a new leader for the FDA by Nov. 1…”
“The current acting FDA commissioner is Ned Sharpless, former director of the National Cancer Institute, who theoretically could also be appointed to the position. Sharpless stepped in after the departure in March of former FDA Commissioner Scott Gottlieb…”
“Giroir, who was appointed in February 2018, leads development of HHS-wide public health policy recommendations and oversees public health offices, such as the U.S. Public Health Service Commissioned Corps…” Read the full article here.
Source: Report: HHS Secretary Azar mulls Brett Giroir as next FDA commissioner – By Allaric Dearment, September 2, 2019. MedCity News.
